However, LOX-1expression in PBMCs was 2~3 times greater in RA patients (median 2.29, IQR 0.63–4.09) than in healthy controls (median 0.61, IQR 0.36–1.28, p < 0.05; Figure 2C). The gene discussed is LOX; the disease is rheumatoid arthritis.